Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Creating CTL targets with epitope-linked beta 2-microglobulin constructs

R A Uger1, B H Barber

  • 1Department of Immunology, University of Toronto, Canada.

Journal of Immunology (Baltimore, Md. : 1950)
|February 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the interaction between antigen and MHC molecules.

Immunology today·2014
Same author

The use of bone marrow-chimeric mice in determining the MHC restriction of epitope-specific cytotoxic T lymphocytes.

Methods in molecular medicine·2011
Same author

The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Sequence and peptide-binding motif for a variant of HLA-A*0214 (A*02142) in an HIV-1-resistant individual from the Nairobi Sex Worker cohort.

Immunogenetics·2001
Same author

Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Journal of virology·2001
Same author

The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission.

The Journal of infectious diseases·2001
Same journal

Optineurin restrains IL-17-associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Crystal structure and immune single-cell atlas provide insights into the functional divergence of type I IFNs in fish.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

An MR1-specific nanobody capable of blocking MR1T cell activation.

Journal of immunology (Baltimore, Md. : 1950)·2026
See all related articles

Researchers engineered novel peptide-linked beta 2-microglobulin (beta 2m) molecules to enhance cytotoxic T lymphocyte (CTL) responses. These constructs effectively present viral epitopes, paving the way for new in vivo immunization strategies.

Area of Science:

  • Immunology and Molecular Biology
  • T-cell mediated immunity
  • Vaccine development

Background:

  • Effective cytotoxic T lymphocyte (CTL) responses require high surface levels of specific MHC class I/peptide complexes.
  • Current methods for enhancing CTL responses face limitations in antigen presentation efficiency.

Purpose of the Study:

  • To engineer and evaluate novel peptide-linked beta 2-microglobulin (beta 2m) fusion proteins.
  • To determine if these fusion proteins can enhance the presentation of viral epitopes for CTL recognition.
  • To explore the potential of these constructs for in vivo induction of epitope-specific CTL responses.

Main Methods:

  • Construction of two distinct peptide-linked beta 2m molecules: NP(366-374)-L8-h beta 2m and NP(147-155)-L12-h beta 2m.

Related Experiment Videos

  • Transfection of vectors encoding fusion proteins into relevant cell lines (e.g., H-2b, H-2d expressing).
  • Assessment of target cell lysis by specific CTLs.
  • Analysis of cell surface-bound peptides and inhibition assays using competitor wild-type beta 2m.

    • Main Results:

    • Transfected cells expressing NP(366-374)-L8-h beta 2m were effectively lysed by specific CTLs, indicating successful antigen presentation.
    • CTL recognition was mediated by the intact peptide-linked beta 2m, not free peptide by-products.
    • Exogenous application of NP(147-155)-L12-h beta 2m also sensitized target cells for lysis, demonstrating efficacy via an external pathway.

    Conclusions:

    • Covalently linking peptides to beta 2m creates effective CTL target structures both intracellularly and extracellularly.
    • These engineered beta 2m fusion proteins offer a promising strategy for in vivo induction of epitope-specific CTL responses.
    • Potential applications include DNA immunization or direct injection of purified epitope-linked beta 2m for enhanced immunotherapy.